These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19496708

  • 1. Rituximab and chemotherapy in diffuse large B-cell lymphoma.
    Sonet A, Bosly A.
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):719-26. PubMed ID: 19496708
    [Abstract] [Full Text] [Related]

  • 2. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, Armitage JO, Chan WC, Vose JM.
    J Clin Oncol; 2008 Oct 01; 26(28):4587-94. PubMed ID: 18662967
    [Abstract] [Full Text] [Related]

  • 3. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
    Lin TY, Zhang HY, Huang Y, Guan ZZ, Shen T, Shi YK, Zhu J, Ke XY, Wang HQ, Shen ZX, Yu SY, Liu T, Shi XL.
    Ai Zheng; 2005 Dec 01; 24(12):1421-6. PubMed ID: 16351785
    [Abstract] [Full Text] [Related]

  • 4. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
    Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O'Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM.
    J Clin Oncol; 2005 Aug 01; 23(22):5027-33. PubMed ID: 15955905
    [Abstract] [Full Text] [Related]

  • 5. Rituximab for the treatment of diffuse large B-cell lymphomas.
    Held G, Pöschel V, Pfreundschuh M.
    Expert Rev Anticancer Ther; 2006 Aug 01; 6(8):1175-86. PubMed ID: 16925484
    [Abstract] [Full Text] [Related]

  • 6. Unresolved issues in diffuse large B-cell lymphomas.
    Murawski N, Zwick C, Pfreundschuh M.
    Expert Rev Anticancer Ther; 2010 Mar 01; 10(3):387-402. PubMed ID: 20214520
    [Abstract] [Full Text] [Related]

  • 7. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R, Hagenbeek A.
    Eur J Haematol Suppl; 2007 Jan 01; (67):5-14. PubMed ID: 17206982
    [Abstract] [Full Text] [Related]

  • 8. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
    Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ.
    J Clin Oncol; 2006 Jul 01; 24(19):3121-7. PubMed ID: 16754935
    [Abstract] [Full Text] [Related]

  • 9. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
    Lin PC, Hsiao LT, Poh SB, Wang WS, Yen CC, Chao TC, Liu JH, Chiou TJ, Chen PM.
    Ann Hematol; 2007 Feb 01; 86(2):95-100. PubMed ID: 17031689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Management of diffuse large B-cell lymphoma in the rituximab era].
    Kinoshita T.
    Rinsho Ketsueki; 2009 Oct 01; 50(10):1342-50. PubMed ID: 19915341
    [No Abstract] [Full Text] [Related]

  • 13. Standard treatment of advanced-stage diffuse large B-cell lymphoma.
    Coiffier B.
    Semin Hematol; 2006 Oct 01; 43(4):213-20. PubMed ID: 17027655
    [Abstract] [Full Text] [Related]

  • 14. Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.
    Yamaguchi T, Takahashi H, Kagawa R, Takeda R, Sakata S, Nishizaki D, Takamatsu T, Iwasa Y.
    Hepatogastroenterology; 2008 Oct 01; 55(84):891-4. PubMed ID: 18705290
    [Abstract] [Full Text] [Related]

  • 15. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
    Kim SJ, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS.
    Eur J Haematol; 2008 Sep 01; 81(3):177-84. PubMed ID: 18510703
    [Abstract] [Full Text] [Related]

  • 16. Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.
    Gisselbrecht C.
    Br J Haematol; 2008 Dec 01; 143(5):607-21. PubMed ID: 18950460
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.